GlassScriptPhysician profile
Seshadri Kasturi
NPI 1154555340
$35,703.29
in general payments reported to CMS, 2019-2025
25 companies · $318 in 2025
The $318 reported for 2025 was less than what a typical Urogynecology and Reconstructive Pelvic Surgery (Urology) provider received nationally (typical 2025 total: $782).
See the full distribution for Urogynecology and Reconstructive Pelvic Surgery (Urology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $624 · 2020: $4,880 · 2021: $6,715 · 2022: $9,476 · 2023: $587 · 2024: $13K · 2025: $318.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,675 · Travel and Lodging: $2,254 · Food and Beverage: $1,968 · Education: $82.65 · Gift: $28.88.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,674.74 |
| Travel and Lodging | $2,254.04 |
| Food and Beverage | $1,968.43 |
| Education | $82.65 |
| Gift | $28.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $32,049.20 | 2019-2025 | Saffron |
| Pfizer INC. | $738.15 | 2019-2023 | |
| Allergan, INC. | $471.67 | 2019-2022 | |
| Abbvie INC. | $347.52 | 2019-2025 | |
| Astellas Pharma US INC | $304.35 | 2019-2023 | Myrbetriq |
| Sumitomo Pharma America, INC. | $283.32 | 2023-2025 | Gemtesa |
| Boston Scientific Corporation | $248.87 | 2021-2024 | Upsylon, Lynx System, Solyx Sis System |
| Urovant Sciences INC | $215.14 | 2021-2022 | |
| Caldera Medical, INC | $183.07 | 2022-2025 | Desara |
| Therapeuticsmd, INC. | $157.54 | 2019-2020 | |
| Axonics, INC. | $129.04 | 2020-2022 | |
| Amag Pharmaceuticals, INC. | $90.52 | 2019-2020 | |
| Hologic Sales and Service, LLC | $72.03 | 2019-2025 | Aptima |
| C. R. Bard, INC. & Subsidiaries | $61.58 | 2019-2024 | Bard Urinary Drainage Bag |
| Femselect INC. | $60.87 | 2025 | Enplace |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $57.73 | 2020-2025 | Vistaseal |
| Convatec INC. | $53.84 | 2024-2025 | |
| Olympus America INC. | $42.15 | 2020 | |
| Laborie Medical Technologies Corp. | $28.21 | 2020-2024 | Eclipse |
| Merz North America, INC. | $26.27 | 2024 | |
| 180 Medical, INC. | $22.72 | 2024 | Speedicath |
| Vertex Pharmaceuticals Incorporated | $20.56 | 2025 | |
| Rochester Medical Corporation | $17.48 | 2021 | |
| Baxter Healthcare | $15.26 | 2019 | |
| Mayne Pharma Commercial LLC | $6.20 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seshadri Kasturi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.